Company Overview
About INBRAIN Neuroelectronics
INBRAIN Neuroelectronics is a neurotechnology company founded in 2019 as a spin-out from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) in Barcelona, Spain. The company develops minimally invasive brain-computer interfaces built on graphene — a single layer of carbon atoms with exceptional electrical conductivity, biocompatibility, and transparency to MRI imaging. INBRAIN's graphene electrodes enable higher spatial resolution neural sensing and more precise, adaptive stimulation than conventional metal electrodes used in implantable neurostimulators.
Business Model & Competitive Advantage
The company raised €30M in a Series B round in 2024, with investors including Neurotech Capital and other European deeptech funds, bringing total funding to over €50M. INBRAIN's clinical strategy focuses on neuromodulation indications with high unmet need: Parkinson's disease, epilepsy, treatment-resistant depression, and obsessive-compulsive disorder. Its AI-driven signal processing layer enables closed-loop stimulation — the device reads neural signals, interprets them with machine learning algorithms, and adjusts stimulation parameters in real time to optimize therapeutic effect, personalizing treatment to each patient's moment-to-moment brain state.
Competitive Landscape 2025–2026
INBRAIN has achieved first-in-human implantation milestones and is advancing through clinical development under regulatory oversight in Europe. The company's graphene interface technology has applications beyond therapeutic neuromodulation — including brain-computer interfaces for motor rehabilitation and future neurocognitive augmentation — positioning INBRAIN at the frontier of both medical device regulation and emerging neural interface technology. The company collaborates with academic medical centers and neurosurgical teams across Europe to generate the clinical evidence required for CE Mark approval.
Frequently Asked Questions
Estimated Visibility Trend (Beta)
Simulated 8-week rolling score
Based on estimated brand signals. Historical tracking coming soon.
Similar Brands
Emulate
Emulate, Inc. is a Boston-based biotechnology company that designs, manufactures, and commercializes Organ-Chip technology — micro-engineered devices lined with living human cells that replicate the m
Neuralink
Neuralink is a neurotechnology company founded in 2016 by Elon Musk and a team of neuroscientists and engineers, developing implantable brain-computer interface devices that enable individuals with pa
Saluda Medical
Saluda Medical is a commercial-stage medical device company that has pioneered closed-loop neuromodulation therapy for chronic pain management. Headquartered in Macquarie Park, Australia (with US oper
Tempus
Tempus AI is a technology company applying artificial intelligence to advance precision medicine across oncology, neurology, psychiatry, and cardiology. Founded in 2015 by Eric Lefkofsky (co-founder o
Karius
Karius is a Redwood City, CA-based life sciences company founded in 2014 that developed the Karius Test — a single blood draw that uses next-generation sequencing and AI to detect over 1,000 pathogens
ConcertAI
ConcertAI is a Boston-based company that combines artificial intelligence with real-world oncology data to accelerate cancer drug development and improve patient outcomes. Its platform integrates mult
Compare INBRAIN Neuroelectronics with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from INBRAIN Neuroelectronics? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim INBRAIN Neuroelectronics Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention INBRAIN Neuroelectronics vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →